GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

Share Price Information for Braveheart Investments (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.75
Bid: 5.50
Ask: 6.00
Change: -0.25 (-4.17%)
Spread: 0.50 (9.091%)
Open: 6.00
High: 6.00
Low: 5.75
Prev. Close: 6.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Nomad & Broker and Directorate Changes

3 Mar 2016 07:00

RNS Number : 8541Q
Braveheart Investment Group plc
03 March 2016
 

Braveheart Investment Group plc

('Braveheart', the 'Company')

 

Change of Nominated Adviser & Broker

Directorate Changes

Braveheart Investment Group plc (AIM: BRH), the financial services company that facilitates SME growth through investment by private sector sources,  is pleased to announce that it has appointed Allenby Capital Limited ("Allenby") as its nominated adviser and broker. This decision has been made in light of Allenby's acquisition of the corporate finance function of the Company's previous nominated adviser, Sanlam Securities (UK) Limited, and the Company's desire to retain continuity with one of its key advisers.

The Company also announces that Martin Bowles, non-executive director of the Company, has today stepped down from the board in order to concentrate on his other business activities. The board would like to thank Martin for his contribution to the Company over the past 18 months.

Furthermore, Jonathan Freeman is today moving from his role as an executive director to become a non-executive director of the Company.

 

Further information:

Braveheart Investment Group plc

Jeremy Delmar-Morgan, Chairman Tel: +44 1738 587555

Trevor Brown, CEO

 

Allenby Capital Limited (Nominated Adviser and Broker to Braveheart)

Simon Clements/James Thomas Tel: +44 20 7628 2200

 

 

Notes to Editors:

Braveheart Investment Group provides a range of products and services to investors seeking exposure to SME investments. Our clients include high-net-worth individuals looking to build tax-efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios, public-sector organisations, family offices and other institutions. Products available range from self-build portfolios to a full fund management service.

 

 

Funds managed by Braveheart and its subsidiaries companies include; the Finance Yorkshire Equity Fund, the Lachesis Fund, the Strathclyde Innovation Fund, the Viking Growth Fund and the Viking Loan Fund. Our operating companies are Strathtay Ventures Ltd and Viking Fund Managers Ltd.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPUGUAUWUPQGMP
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.